+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Continuous Blood Glucose Monitoring Systems Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025

  • ID: 4770336
  • Report
  • Region: Global
  • 100 pages
  • Infinium Global Research
UP TO OFF
until Dec 31st 2019
1 of 3

FEATURED COMPANIES

  • Abbott
  • Bayer AG
  • Dexcom, Inc.
  • Integrity Applications
  • Medtronic
  • Nano Nordisk
  • MORE
The report on the global continuous blood glucose monitoring systems market provides qualitative and quantitative analysis for the period from 2017 to 2025. The report predicts the global continuous blood glucose monitoring systems market to grow with a CAGR of 23.1% over the forecast period from 2019-2025. The study on continuous blood glucose monitoring systems market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2017 to 2025.

The report on continuous blood glucose monitoring systems market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global continuous blood glucose monitoring systems market over the period of 2017 to 2025. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global continuous blood glucose monitoring systems market over the period of 2017 to 2025. Further, IGR- Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings
1) Drivers
  • Growing prevalence of diabetes worldwide
  • Benefits of CBGM devices over blood glucometers
  • Increasing preference for non-invasive methods
2) Restraints
  • Stringent regulatory approvals
3) Opportunities
  • Growing healthcare expenditures
  • Ongoing advancements in the glucose monitoring system
Research Methodology
A) Primary Research

Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include
1. Key Opinion Leaders associated with the Publisher
2. Internal and External subject matter experts
3. Professionals and participants from the industry

Our primary research respondents typically include
1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.

B) Secondary Research

Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include
1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered
The global continuous blood glucose monitoring systems market is segmented on the basis of component.

The Global Continuous Blood Glucose Monitoring Systems Market by Component
  • CGM Monitor
  • CGM Transmitter
  • Glucose Sensor
Company Profiles
The companies covered in the report include
  • Dexcom, Inc.
  • Medtronic
  • Abbott
  • Integrity Applications
  • Nano Nordisk
  • OrSense
  • Bayer AG
  • Johnson & Johnson Services
  • Senseonics Holdings
  • Others
What does this report deliver?
1. Comprehensive analysis of the global as well as regional markets of the continuous blood glucose monitoring systems market.
2. Complete coverage of all the segments in the continuous blood glucose monitoring systems market to analyze the trends, developments in the global market and forecast of market size up to 2025.
3. Comprehensive analysis of the companies operating in the global continuous blood glucose monitoring systems market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and the latest developments of the company.
4. IGR- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abbott
  • Bayer AG
  • Dexcom, Inc.
  • Integrity Applications
  • Medtronic
  • Nano Nordisk
  • MORE
1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches

2. Executive Summary
2.1. Continuous Blood Glucose Monitoring Systems Market Highlights
2.2. Continuous Blood Glucose Monitoring Systems Market Projection
2.3. Continuous Blood Glucose Monitoring Systems Market Regional Highlights

3. Global Continuous Blood Glucose Monitoring Systems Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. IGR-Growth Matrix Analysis
3.4.1. IGR-Growth Matrix Analysis by Component
3.4.2. IGR-Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Continuous Blood Glucose Monitoring Systems Market

4. Continuous Blood Glucose Monitoring Systems Market Macro Indicator Analysis

5. Global Continuous Blood Glucose Monitoring Systems Market by Component
5.1. CGM Monitor
5.2. CGM Transmitter
5.3. Glucose Sensor

6. Global Continuous Blood Glucose Monitoring Systems Market by Region 2019-2025
6.1. North America
6.1.1. North America Continuous Blood Glucose Monitoring Systems Market by Component
6.1.2. North America Continuous Blood Glucose Monitoring Systems Market by Country
6.2. Europe
6.2.1. Europe Continuous Blood Glucose Monitoring Systems Market by Component
6.2.2. Europe Continuous Blood Glucose Monitoring Systems Market by Country
6.3. Asia-Pacific
6.3.1. Asia-Pacific Continuous Blood Glucose Monitoring Systems Market by Component
6.3.2. Asia-Pacific Continuous Blood Glucose Monitoring Systems Market by Country
6.4. RoW
6.4.1. RoW Continuous Blood Glucose Monitoring Systems Market by Component
6.4.2. RoW Continuous Blood Glucose Monitoring Systems Market by Sub-region

7. Company Profiles and Competitive Landscape
7.1. Competitive Landscape in the Global Continuous Blood Glucose Monitoring Systems Market
7.2. Companies Profiles
7.2.1. Dexcom, Inc.
7.2.2. Medtronic
7.2.3. Abbott
7.2.4. Integrity Applications
7.2.5. Nano Nordisk
7.2.6. OrSense
7.2.7. Bayer AG
7.2.8. Johnson & Johnson Services
7.2.9. Senseonics Holdings
7.2.10. Others

8. Appendix
8.1. Primary Research Findings and Questionnaire
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Dexcom, Inc.
  • Medtronic
  • Abbott
  • Integrity Applications
  • Nano Nordisk
  • OrSense
  • Bayer AG
  • Johnson & Johnson Services
  • Senseonics Holdings
Note: Product cover images may vary from those shown
Adroll
adroll